News
- Author:
- Nancy A. Melville
Publish date: January 4, 2022
The findings “underscore the fact that the desensitization achieved with peanut oral immunotherapy is a transient immune state.”
News
- Author:
- Nancy A. Melville
Publish date: December 28, 2021
“To our knowledge, this analysis presents the first and largest investigation of vaccination rates among people w...
News
- Author:
- Nancy A. Melville
Publish date: December 17, 2021
“This will save tens of thousands of women the time, expense, and potentially harmful side effects that can be associated with chemotherapy infusio...
News
- Author:
- Nancy A. Melville
Publish date: December 17, 2021
Only 25%-30% of adults in the U.S. are reported to be currently vaccinated for hepatitis B, even though safe and highly effective vaccines are avai...
News
- Author:
- Nancy A. Melville
Publish date: December 15, 2021
The number of CDC-funded HIV tests declined by more than 1 million in 2020 amid the COVID-19 restrictions.
News
- Author:
- Nancy A. Melville
Publish date: December 15, 2021
People with HIV are known to be at an increased risk of diabetes and the long-term complications of the disease.
News
- Author:
- Nancy A. Melville
Publish date: December 8, 2021
Adding ibrutinib to standard chemotherapy improves DLBCL survival in younger patients, especially among certain genetic subtypes.
News
- Author:
- Nancy A. Melville
Publish date: December 8, 2021
Compared with nonthyroid cancer patients, those receiving thyroidectomy for thyroid cancer show up to a 40% greater risk for diabetes.
News
- Author:
- Nancy A. Melville
Publish date: December 7, 2021
New data suggest benefits of drug monitoring to assess risks for pancreatitis and other toxicities.
News
- Author:
- Nancy A. Melville
Publish date: December 6, 2021
While extraordinary advances have transformed treatment and prevention, glaring treatment gaps and challenges rem...
News
- Author:
- Nancy A. Melville
Publish date: November 29, 2021
Interventions during ages 18-25 seen as key to shift unhealthy trajectory.
News
- Author:
- Nancy A. Melville
Publish date: November 17, 2021
A subanalysis of renal effects in the phase 3 ADVOCATE trial found that avacopan improved estimated glomerular filtration rate best among patients ...
News
- Author:
- Nancy A. Melville
Publish date: November 16, 2021
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers showed the strongest association with preventive effects.
News
- Author:
- Nancy A. Melville
Publish date: November 11, 2021
While “surprising,” these findings do not prove that B-cell repletion does not put someone at risk.
News
- Author:
- Nancy A. Melville
Publish date: November 10, 2021
The automated NIH Toolbox Cognition Battery may be used as an alternative to other gold-standard measures which may cover limited domains or requir...
